Mitochondria-Targeting Particles
- 1 November 2014
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 9 (16) , 2531-2543
Abstract
Mitochondria are a promising therapeutic target for the detection, prevention and treatment of various human diseases such as cancer, neurodegenerative diseases, ischemia-reperfusion injury, diabetes and obesity. To reach mitochondria, therapeutic molecules need to not only gain access to specific organs, but also to overcome multiple barriers such as the cell membrane and the outer and inner mitochondrial membranes. Cellular and mitochondrial barriers can be potentially overcome through the design of mitochondriotropic particulate carriers capable of transporting drug molecules selectively to mitochondria. These particulate carriers or vectors can be made from lipids (liposomes), biodegradable polymers, or metals, protecting the drug cargo from rapid elimination and degradation in vivo. Many formulations can be tailored to target mitochondria by the incorporation of mitochondriotropic agents onto the surface and can be manufactured to desired sizes and molecular charge. Here, we summarize recently report...Keywords
This publication has 81 references indexed in Scilit:
- Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondriaCell Death & Disease, 2013
- CaMKII determines mitochondrial stress responses in heartNature, 2012
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Dual Function MITO-Porter, a Nano Carrier Integrating Both Efficient Cytoplasmic Delivery and Mitochondrial Macromolecule DeliveryMolecular Therapy, 2011
- Is mPTP the gatekeeper for necrosis, apoptosis, or both?Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Small mitochondria-targeting molecules as anti-cancer agentsMolecular Aspects of Medicine, 2010
- Mitochondria: A therapeutic target in neurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Mitochondrial Medicine for Aging and Neurodegenerative DiseasesNeuroMolecular Medicine, 2008
- Intracellular Distribution of TiO2−DNA Oligonucleotide Nanoconjugates Directed to Nucleolus and Mitochondria Indicates Sequence SpecificityNano Letters, 2007
- Mitochondrial DNA mutations in human diseaseNature Reviews Genetics, 2005